Tumor dosimetry of [(177)Lu]Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: Results from the VISION trial sub-study Meeting Abstract

  


Authors: Krause, B. J.; Chi, K. N.; Sartor, A. O.; Fizazi, K.; Morris, M. J.; De Bono, J. S.; Tagawa, S. T.; Herrmann, K.; Kurth, J.; Eiber, M.; Lassmann, M.; Jentzen, W.; Sparks, R.; Baca, N.; Nguyen, Q.; Blumenstein, L.; Klein, P.; Wilke, C.; Basque, J. R.; Rahbar, K.
Abstract Title: Tumor dosimetry of [(177)Lu]Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: Results from the VISION trial sub-study
Meeting Title: 2023 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 16 Suppl.
Meeting Dates: 2023 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-06-01
Language: English
DOI: 10.1200/JCO.2023.41.16_suppl.5046
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:

https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=164014223&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes: Meeting Abstract: 5046 -- This meeting was also held virtually -- Source: Cinahl
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    587 Morris
Related MSK Work